Quadron Cannatech (CSE:QCC) shared with investors its financial and operating results for the its 2018 Q1, which ended on July 31.

As quoted in the press release:

First quarter financial highlights (unaudited):

  • Revenue of $968,783, an 87.7 [percent] increase over Q1 July 31, 2017 and a 282 [percent] increase over Q4 2017;
  • Gross margin of $285,530 or 29 [percent] vs 26 [percent] in Q1 July 31, 2017. Gross margins fluctuate dependent upon product mix;
  • Loss of $1,137,597 compared to $416,820 for Q1 July 31, 2017. The increased loss for the quarter includes stock based compensation of $265,129, an increase in development and research of approximately $185,404, and increases in staffing and infrastructure relating to the Company’s further development of its extraction equipment and processes; and
  • Cash of $2,981,444 and working capital of $5,075,413 at quarter end.

“We have devoted a significant amount of resources toward the research and development of our automated extraction and processing equipment, in preparation for the legalization of the recreational market and the eventual inclusion of extract derived products,” states Rosy Mondin, CEO.

Click here to read the full press release.

Source: globenewswire.com

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less